Related Experiment Videos
Potential nondopaminergic drugs for Parkinson's disease
Monty A Silverdale1, S H Fox, A R Crossman
1Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.
Advances in Neurology
|November 22, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.
Movement disorders : official journal of the Movement Disorder Society·2026
Update on Treatments for Parkinson's Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.
Movement disorders : official journal of the Movement Disorder Society·2025
Generalized Dystonia Due to a Pathogenic THAP1 Variant Showing Sustained Response to Globus Pallidus Deep Brain Stimulation.
Tremor and other hyperkinetic movements (New York, N.Y.)·2023
Special Issue on new therapeutic approaches to Parkinson disease.
Neuropharmacology·2022
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Cendakimab for Eosinophilic Gastritis and Duodenitis in Japanese Adults and Adolescents: Results From a Phase 3 Randomized Controlled Trial.
The American journal of gastroenterology·2026
Buprenorphine Dispensed by Pharmacies and Administered in Emergency Departments in Urban and Rural Areas - United States, 2019-2025.
MMWR. Morbidity and mortality weekly report·2026
Rheumatoid Arthritis Guidelines Require Dietary Recommendations: An Overlooked Opportunity.
Clinical nutrition ESPEN·2026
Assessment of the impact of valproic acid co-administration on clozapine plasma concentrations in Tunisian patients.
Drug metabolism and personalized therapy·2026
Benefit-Risk of Voxelotor, Crizanlizumab, and L-Glutamine in Sickle Cell Disease: A Systematic Review.
The American journal of the medical sciences·2026